Esperion Therapeutics Stock Forecast

Buy or Hold candidate since May 04, 2026 Gain 0.32%

No changes to the price of Esperion Therapeutics stock on the last trading day (Friday, 5th Jun 2026). During the last trading day the stock fluctuated 0.319% from a day low at $3.13 to a day high of $3.14. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 22.84% during the next 3 months and, with a 90% probability hold a price between $2.75 and $4.57 at the end of this 3-month period.

ESPR Signals & Forecast

The Esperion Therapeutics stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $3.13. On a fall, the stock will find some support from the long-term average at approximately $2.79. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, May 06, 2026, and so far it has fallen -0.635%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Esperion Therapeutics stock

Esperion Therapeutics finds support from accumulated volume at $3.12 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0.0100 between high and low, or 0.319%. For the last week the stock has had daily average volatility of 0.352%

Our recommended stop-loss: $3.01 (-3.81%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 21 days ago.)

Trading Expectations (ESPR) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Esperion Therapeutics to open at $3.13, and during the day (based on 14 day Average True Range), to move between $3.10 and $3.16, which gives a possible trading interval of +/-$0.0522 (+/-1.68%) up or down from last closing price. If Esperion Therapeutics takes out the full calculated possible swing range there will be an estimated 1.68% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.12 (0.32%) than the resistance at $3.14 (0.32%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Esperion Therapeutics stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Esperion Therapeutics stock to perform well in the short-term.

Current score: 1.026 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $3.13 ( 0.106%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk